Dengue Moment
For a country that has lived with dengue as a seasonal inevitability, the emergence of DengiAll, India’s indigenous single-shot dengue vaccine now in advanced trials in Delhi, is more than a scientific milestone.
For a country that has lived with dengue as a seasonal inevitability, the emergence of DengiAll, India’s indigenous single-shot dengue vaccine now in advanced trials in Delhi, is more than a scientific milestone.
The World Health Organization (WHO) has donated 2,160 doses of Ebola trial vaccine to Uganda to evaluate the efficacy of the vaccine in combating the virus which in the recent outbreak has killed a health worker in Kampala, the country's capital.
Indonesia is developing a new Tuberculosis (TB) vaccine to strengthen the fight against TB, which has claimed an average of 150,000 lives annually.
The landmark trial will evaluate the efficacy of India’s indigenous tetravalent dengue vaccine, DengiAll, developed by Panacea Biotec.
Specifically, the team compared the immune responses in people who were protected against CMV infection after receiving the older vaccine.
It has become the first state in the country to achieve 100 per cent administration of the first dose COVID vaccine to its eligible population, Thakur further said.
"When you add to that its versatility in forming other words - vaxxie, vax-a-thon, vaxinista - it became clear that vax was the standout in the crowd", Fiona said.
WHO spokesperson Margaret Harris told journalists in Geneva that at least 87 children have died due to measles this year.
The development has come after the World Health Organisation approved Covaxin for emergency use listing last week.
The majority of new infections were in Victoria, the country's second-most populous state, where 1,268 cases and seven deaths were reported.
